The primary goal of this highly competitive training program is to prepare graduate students and fellows to become leading researchers in Alzheimer’s disease and related neurodegenerative dementing disorders. A special emphasis of this research training program is to train fellows to conduct basic, translational, and clinical research that brings basic science to clinical practice. This training program is open to graduate students, basic science PhDs, MDs, MD/PhDs, and Clinical Psychologist PhDs.
Psychiatry Fellowship, Research Fellowship, T-32 Training Grant
Our training program is the only formal program at the University of Washington focused on training investigators to carry out basic, clinical, and translational research in AD and related neurodegenerative dementing disorders. Our program is supported by the rich and interactive research environment of the University of Washington and Veterans Affairs Puget Sound Health Care System, where a critical mass of faculty conduct research across the spectrum of AD and related dementias.
The program supports training positions for 7 postdoctoral trainees focused on either clinical or basic/translational dementia research. Incoming MD candidates are expected to have completed a residency, usually in psychiatry, neurology, neuropathology, radiology, internal medicine, or geriatric medicine. Postdoctoral PhD candidates come from a broad range of disciplines, including clinical psychology, neuropsychology, biochemistry, genetics, neurobiology, and pharmacology. Basic science trainees typically join the program during their 1st year of postgraduate training and usually remain for three years. MD and clinician PhD fellows are expected to remain for a two year period, and will be strongly encouraged to remain for a third.
The program also supports training positions for 4 predoctoral candidates. Predoctoral trainees will be recruited from the following UW PhD programs: Genome Sciences, Molecular Basis of Disease, Molecular and Cellular Biology, Neurobiology and Behavior, and Pharmacology, and will join the ADTP program in their 2nd or 3rd year of graduate training. Special recruitment efforts will be made to include underserved minority trainees.